These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33419606)

  • 21. Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.
    Sawayanagi S; Yamashita H; Ogita M; Takenaka R; Nozawa Y; Watanabe Y; Imae T; Abe O
    Radiat Oncol; 2022 Feb; 17(1):41. PubMed ID: 35197092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
    Mazzola R; Sicignano G; Cuccia F; Vitale C; Rigo M; Giaj-Levra N; Nicosia L; Figlia V; Ricchetti F; Attinà G; Pastorello E; De Simone A; Gurrera D; Naccarato S; Ruggieri R; Alongi F
    Br J Radiol; 2021 Oct; 94(1126):20210521. PubMed ID: 34283646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.
    Dinh TT; Lee HJ; Macomber MW; Apisarnthanarax S; Zeng J; Laramore GE; Rengan R; Russell KJ; Chen JJ; Ellis WJ; Schade GR; Liao JJ
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):635-643. PubMed ID: 32035187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.
    Leiker AJ; Desai NB; Folkert MR
    Future Oncol; 2018 Nov; 14(26):2773-2788. PubMed ID: 29939069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion.
    Te Velde BL; Westhuyzen J; Awad N; Wood M; Shakespeare TP
    J Med Imaging Radiat Oncol; 2019 Dec; 63(6):836-841. PubMed ID: 31520465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
    Karsh LI; Gross ET; Pieczonka CM; Aliotta PJ; Skomra CJ; Ponsky LE; Nieh PT; Han M; Hamstra DA; Shore ND
    Urology; 2018 May; 115():39-44. PubMed ID: 29174940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR).
    Sturt P; Suh YE; Khoo V
    Med Dosim; 2022 Summer; 47(2):173-176. PubMed ID: 35277316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy.
    Qi XS; Wang JP; Gomez CL; Shao W; Xu X; King C; Low DA; Steinberg M; Kupelian P
    Radiother Oncol; 2016 Oct; 121(1):113-117. PubMed ID: 27587270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
    Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
    Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.
    Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J
    Pract Radiat Oncol; 2017; 7(3):195-202. PubMed ID: 28089528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity.
    Henderson DR; Murray JR; Gulliford SL; Tree AC; Harrington KJ; Van As NJ
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):539-547. PubMed ID: 29807801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.
    Hwang ME; Mayeda M; Liz M; Goode-Marshall B; Gonzalez L; Elliston CD; Spina CS; Padilla OA; Wenske S; Deutsch I
    Radiat Oncol; 2019 Aug; 14(1):136. PubMed ID: 31375119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.
    Alshak MN; Eidelberg A; Diaz SM; Stoddard MD; Formenti S; Nagar H; Kang J; Chughtai B
    World J Urol; 2022 May; 40(5):1143-1150. PubMed ID: 35182206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
    Kahn J; Dahman B; McLaughlin C; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
    Brachytherapy; 2020; 19(2):228-233. PubMed ID: 32085930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.
    Padmanabhan R; Pinkawa M; Song DY
    Future Oncol; 2017 Dec; 13(29):2697-2708. PubMed ID: 29168659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
    Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
    Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.
    Kim DW; Cho LC; Straka C; Christie A; Lotan Y; Pistenmaa D; Kavanagh BD; Nanda A; Kueplian P; Brindle J; Cooley S; Perkins A; Raben D; Xie XJ; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):509-17. PubMed ID: 24929162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy.
    van Gysen K; Kneebone A; Alfieri F; Guo L; Eade T
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):511-6. PubMed ID: 24580893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximizing rectal dose sparing with hydrogel: A retrospective planning study.
    Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A
    J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.